Olanzapine

(Date of issue: January 2015. Version: 2)

This factsheet has been written for members of the public by the UK Teratology Information Service (UKTIS). UKTIS is a not-for-profit organisation funded by Public Health England on behalf of UK Health Departments. UKTIS has been providing scientific information to health care providers since 1983 on the effects that medicines, recreational drugs and chemicals may have on the developing baby during pregnancy.

What is it?

Olanzapine (Zalasta®, Zyprexa®) belongs to a group of medicines called atypical antipsychotics and is used to treat schizophrenia, mania, and to prevent recurrence of bipolar disorder.

Is it safe to take olanzapine in pregnancy?

There is no yes or no answer to this question. When deciding whether or not to take olanzapine during pregnancy it is important to weigh up how necessary olanzapine is to your health against the possible risks to you or your baby, some of which will depend on how many weeks pregnant you are. Remaining well is particularly important during pregnancy and while caring for a baby. For some women treatment with olanzapine in pregnancy may be necessary.

This leaflet summarises the scientific studies relating to the effects of olanzapine on a baby in the womb. It is advisable to consider this information before taking olanzapine if you are pregnant. Your doctor is the best person to help you decide what is right for you and your baby.

What if I have already taken olanzapine during pregnancy?

If you have taken or are taking any medicines it is always a good idea to let your doctor know that you are pregnant so that you can decide together whether you still need the medicines that you are on and, if so, to make sure that you are taking the lowest dose that works and only for as long as you need to.

It is very important that you do not suddenly stop taking olanzapine as this could be dangerous to you and to your baby if you are already pregnant. Do not make any changes to your medication without first talking to your doctor.

Can taking olanzapine in pregnancy cause birth defects in the baby?

A baby’s body and most internal organs are formed during the first 12 weeks of pregnancy. It is mainly during this time that some medicines are known to cause birth defects.

One study that investigated around 1,100 pregnant women who took olanzapine did not show that olanzapine use in pregnancy increases the risk of birth defects in the baby. A very small amount of information from individual case studies has also not provided any warning signals that olanzapine causes birth defects. However, information from many more pregnant women taking olanzapine needs to be collected before we can say for certain that there is no increased risk.

There are several studies that have collected information on babies of women who took any type of antipsychotic medicine during pregnancy. The antipsychotic medicines that women were taking often differ from one study to another. Some of these studies include a small number of women taking olanzapine but they were generally only a small portion of the study group and were not studied separately. The findings of these studies may therefore not be directly relevant to women taking olanzapine but are summarised below for interest:
 

• Three studies showed that women taking any antipsychotic had an increased chance of having a baby with a birth defect, but two further studies found no link between antipsychotic use in early pregnancy and having a baby with a birth defect.

• One study found that around three in every hundred women who took an atypical antipsychotic in pregnancy had a baby with a heart defect compared to one in every hundred women who did not take any medication in pregnancy. No other studies have investigated this and it is therefore not yet clear whether there is a link between atypical antipsychotic use in early pregnancy and heart defects, or whether babies who were exposed to antipsychotics in the womb are more likely to have heart scans that pick up abnormalities that would otherwise not have been known about at birth. Even if it is shown one day that women who take atypical antipsychotics are at increased risk of having a baby with a heart defect, this study suggests that 97 out of every 100 babies born to women taking atypical antipsychotics during pregnancy will not have a heart defect.

Taken together, these studies do not prove that taking antipsychotics during early pregnancy causes birth defects in the baby. Although olanzapine is chemically similar to some of the other antipsychotics, it may affect a baby in the womb differently. We therefore do not know whether the findings from studies of antipsychotics as a group relate to women taking olanzapine and it is very important that information continues to be collected from women who take olanzapine in pregnancy.

Can taking olanzapine in pregnancy cause miscarriage?

No studies have specifically investigated whether women who take olanzapine during early pregnancy are at increased risk of miscarriage.

No increased risk of miscarriage was seen in any of three studies of pregnant women taking different types of antipsychotics, although one further study of a mixed group of women taking antipsychotics or other medicines to treat depression and anxiety did suggest an increased risk of miscarriage.

Some of the women in these studies were taking olanzapine but were not studied separately so we do not know how this information relates specifically to pregnant women taking olanzapine. More information about pregnant women taking olanzapine is needed before any conclusions can be drawn.

Can taking olanzapine in pregnancy cause stillbirth?

No increased risk of stillbirth was seen in one study of pregnant women taking olanzapine. None of five studies of pregnant women taking any antipsychotic showed an increased risk of stillbirth. However, stillbirth rates need to be studied in a larger number of pregnant women specifically taking olanzapine before definite conclusions can be drawn.

Can taking olanzapine in pregnancy cause preterm birth?

There is no evidence from any of three small studies that olanzapine use in pregnancy increases the risk of preterm birth. However, some (but not all) studies of pregnant women taking any antipsychotic have shown an increased risk of preterm delivery. Because only small numbers of women specifically taking olanzapine have been studied, more information on this subject is needed.

Can taking olanzapine in pregnancy affect a baby’s growth in the womb and his/her birth weight?

Low birth weight
There is no evidence from any of three small studies that olanzapine use in pregnancy increases the risk of low birth weight (<2500g). Four studies of pregnant women taking any antipsychotic showed an increased risk of low birth weight, but a further two studies have not agreed with this. Because we do not know whether olanzapine affects a baby in the womb in the same way as other antipsychotics, more information about women specifically taking olanzapine needs to be collected.

Increased birth weight
Weight gain, high blood sugar and diabetes are common side-effects of olanzapine in non-pregnant individuals and have also been reported in pregnant women taking olanzapine. If these problems occur in pregnancy they can in turn cause increased growth of a baby in the womb. Some studies have found that olanzapine may be linked to having a baby that is larger than expected for the stage of pregnancy, but other studies have not agreed with this finding. More research into this subject is therefore required.

Can taking olanzapine in pregnancy cause other health problems in the child?

Withdrawal symptoms at birth (‘neonatal withdrawal’)
Withdrawal symptoms are thought to occur as the newborn baby’s body has to adapt to suddenly no longer getting certain types of medicines through the placenta.

Taking olanzapine and other antipsychotics during pregnancy can lead to neonatal withdrawal. Close monitoring of your baby for a few days after birth may therefore be advised if you have taken olanzapine regularly in the weeks before delivery. 

Learning and behavioural problems
A baby’s brain continues to develop right up until the end of pregnancy. It is therefore possible that taking certain medicines at any stage of pregnancy could have a lasting effect on a child’s learning or behaviour.

No link with learning and behavioural problems (e.g. autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD)) is known about in children who were exposed specifically to olanzapine while in the womb, however no studies have been carried out to specifically investigate this.

One study has analysed learning and behaviour in children whose mothers were treated with any antipsychotic medicine during pregnancy. While babies of mothers who had taken antipsychotics during pregnancy were slightly slower in their development initially, by the time they were one year old there were no differences in developmental test scores between children exposed to antipsychotics in the womb and children who had not been exposed.

One small study showed that six month old babies who had been exposed to any antipsychotic in the womb tended to score lower in developmental tests than babies not exposed to antipsychotics. The babies were not studied again at a later age so we do not know if there were any longer term effects.

More research in this area is needed so that the olanzapine can be specifically studied.

Will my baby need extra monitoring?

Most women will be offered a scan at around 20 weeks of pregnancy to look for birth defects and to check their baby’s growth as part of their routine antenatal care. Taking olanzapine in pregnancy would not normally require extra monitoring of your baby. 

Weight gain and increased blood sugar (hyperglycaemia) can be side-effects of olanzapine. If you are treated with olanzapine during pregnancy your doctor may suggest extra monitoring of your weight and blood sugar levels. If you are gaining more weight than expected, or have high blood sugar levels, extra monitoring of your baby’s growth may be advised as these can be linked to having a bigger baby which may affect where and when your baby is delivered.

If you have taken olanzapine around the time of delivery your baby may require extra monitoring after birth because of the possible risk of neonatal withdrawal. Babies who are large at birth may also need to have their blood sugar monitored for a few days.

Are there any risks to my baby if the father has taken olanzapine?

We would not expect any increased risk to your baby if the father took olanzapine before or around the time you became pregnant.

Who can I talk to if I have questions?

If you have any questions regarding the information in this leaflet please discuss them with your health care provider. They can access more detailed medical and scientific information from www.uktis.org.  

General information 

Up to 1 out of every 5 pregnancies ends in a miscarriage, and 1 in 40 babies are born with a birth defect. These are referred to as the background population risks.  They describe the chance of these events happening for any pregnancy before taking factors such as the mother’s health during pregnancy, her lifestyle, medicines she takes and the genetic make up of her and the baby’s father into account.

Medicines use in pregnancy

Most medicines used by the mother will cross the placenta and reach the baby. Sometimes this may have beneficial effects for the baby.  There are, however, some medicines that can harm a baby’s normal development.  How a medicine affects a baby may depend on the stage of pregnancy when the medicine is taken. If you are on regular medication you should discuss these effects with your doctor/health care team before becoming pregnant.

If a new medicine is suggested for you during pregnancy, please ensure the doctor or health care professional treating you is aware of your pregnancy.

When deciding whether or not to use a medicine in pregnancy you need to weigh up how the medicine might improve your and/or your unborn baby’s health against any possible problems that the drug may cause. Our bumps leaflets are written to provide you with a summary of what is known about use of a specific medicine in pregnancy so that you can decide together with your health care provider what is best for you and your baby.   

Every pregnancy is unique. The decision to start, stop, continue or change a prescribed medicine before or during pregnancy should be made in consultation with your health care provider. It is very helpful if you can record all your medication taken in pregnancy in your hand held maternity records.

   

www.medicinesinpregnancy.org

Disclaimer: This information is not intended to replace the individual care and advice of your health care provider. New information is continually becoming available. Whilst every effort will be made to ensure that this information is accurate and up to date at the time of publication, we cannot cover every eventuality and the information providers cannot be held responsible for any adverse outcomes following decisions made on the basis of this information. We strongly advise that printouts should NOT be kept for any length of time, or for “future reference” as they can rapidly become out of date.

My bump’s record

Create your own ‘My bump’s record’.

Provide information about your pregnancy to help women in the future. 

Login to my bumps

Join my bumps